Monopar Therapeutics (MNPR)
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, which is in phase 1 imaging and dosimetry clinical trial, a radiopharmaceutical imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a Phase1a stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; Excel Diagnostics and Nuclear Oncology Center, for the investigational imaging agent MNPR-101-Zr and investigational therapeutic agent MNPR-101-Lu; license agreement with Alexion to develop and commercialize ALXN1840, a drug candidate for Wilson disease. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Monopar Therapeutics Inc.
NASDAQ:MNPRHealthcare · Biotechnology
-2.21%$70.32
AH$70.32+0.00%vs close
Mkt Cap$472M
Float4.85M
O/S6.71M
Vol
$ Vol
RVOL
Inst Own92.7%
SI23.3%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$13.72M
Total Assets$140.72M
Free Cash Flow-$12.2M
Debt & Equity
Debt 0%
Equity 100%
Total Debt$155K
Total Equity$137.83M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:5Reverse splitAug 13, 20245 shares → 1
Balance Sheet Details
Assets$140.72M
Liabilities$2.89M
Accounts Receivable$0
Accounts Payable$2.74M
Inventory$0
PP&E (Net)$255K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $9.9B | $13.01M | $5.6M | $7.59M | $6.49M | $4.07M | $1.97M | $1.77M | $935K | $280K | $101K |
| Selling, General, and Administrative | $6.8B | $3.16M | $3.23M | $2.95M | $2.63M | $2.44M | $2.36M | $1.63M | $1.17M | $912K | $587K |
| Other | -$16.69B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $14.5M | $0 | $0 |
| Total Operating Expenses | $16.7M | $16.16M | $8.83M | $10.54M | $9.13M | $6.51M | $4.32M | $3.4M | $16.6M | $1.19M | $689K |
| Operating Income (EBIT) | -$16.7M | -$16.16M | -$8.83M | -$10.54M | -$9.13M | -$6.51M | -$4.32M | -$3.4M | -$16.6M | -$1.19M | -$689K |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $103K | $48K | $7K | $0 |
| Interest Income | $2.99M | $404K | $429K | $21K | $24K | $82K | $99K | $103K | $48K | $7K | $1K |
| Other Income (Expense) | $2.99M | $575K | $429K | $21K | $24K | $204K | $99K | $31K | $48K | $7K | $1K |
| Income Before Tax (EBT) | -$13.72M | -$15.59M | -$8.4M | -$10.52M | -$9.1M | -$6.3M | -$4.22M | -$3.3M | -$16.55M | -$1.18M | -$687K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$72K | $0 | $800 | $0 |
| Net Income | -$13.72M | -$15.59M | -$8.4M | -$10.52M | -$9.1M | -$6.3M | -$4.22M | -$3.23M | -$16.55M | -$1.19M | -$687K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||||
| EPS | -1.85 | -1.36 | -0.58 | -0.83 | -0.73 | -0.58 | -0.40 | -0.31 | -1.59 | -0.12 | -0.08 |
| Diluted EPS | -1.85 | -1.36 | -0.58 | -0.83 | -0.73 | -0.58 | -0.40 | -0.31 | -1.59 | -0.12 | -0.08 |
| Weighted Average OS | 7.41M | 11.44M | 14.51M | 12.72M | 12.47M | 10.96M | 10.59M | 10.42M | 10.42M | 9.85M | 8.16M |
| EBITDA | -$13.72M | -$15.59M | -$8.4M | -$10.52M | -$9.1M | $0 | -$4.22M | $147 | -$14.45M | $8K | $2K |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $61.83M | $45.82M | $7.27M | $8.19M | $20.3M | $16.74M | $13.21M | $6.89M | $8.98M | $2.07M | $2.01M |
| Short-Term Investments | $78.57M | $14.4M | $0 | $4.93M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $140.4M | $60.21M | $7.27M | $13.12M | $20.3M | $16.74M | $13.21M | $6.89M | $8.98M | $2.07M | $2.01M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $64K | $79K | $66K | $46K | $218K | $63K | $16K | $0 | $0 | $0 | $0 |
| Total Current Assets | $140.46M | $60.29M | $7.33M | $13.17M | $20.52M | $16.8M | $13.23M | $7.32M | $9.13M | $2.1M | $2.03M |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $255K | $0 | $13K | $61K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $730.65M | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $800K | $800K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $69K | $122K | $411K | -$729.85M | $0 | $0 |
| Total Long-Term Assets | $255K | $0 | $13K | $61K | $0 | $69K | $122K | $411K | $800K | $800K | $800K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$411K | $0 | $0 | $0 |
| Total Assets | $140.72M | $60.29M | $7.35M | $13.23M | $20.52M | $16.87M | $13.35M | $7.32M | $9.93M | $2.9M | $2.83M |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $2.74M | $2.25M | $1.76M | $3.13M | $1.58M | $1.18M | $724K | $400K | $312K | $65K | $74K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $2.74M | $5.25M | $1.76M | $3.13M | $1.58M | $1.18M | $724K | $400K | $312K | $65K | $74K |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $155K | $0 | $0 | $8K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.89M | $5.25M | $1.76M | $3.14M | $1.58M | $1.18M | $724K | $400K | $312K | $65K | $74K |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $116 | $112 |
| Common Stock | $7K | $6K | $15K | $13K | $13K | $11K | $11K | $9K | $9K | $0 | $0 |
| Retained Earnings | -$89.51M | -$75.79M | -$60.21M | -$51.8M | -$41.29M | -$32.19M | -$25.88M | -$21.66M | -$18.43M | -$1.87M | -$687K |
| Comprehensive Income & Other | $131K | $36K | -$14K | $9K | -$3K | -$8K | -$11K | -$2K | $0 | $0 | $0 |
| Other Stockholders' Equity | $227.33M | $130.82M | $65.78M | $61.88M | $60.22M | $47.87M | $38.5M | $28.56M | $28.04M | $4.7M | $3.44M |
| Total Equity | $137.83M | $55.04M | $5.59M | $10.09M | $18.94M | $15.69M | $12.63M | $6.92M | $9.62M | $2.83M | $2.75M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $140.72M | $60.29M | $7.35M | $13.23M | $20.52M | $16.87M | $13.35M | $7.32M | $9.93M | $2.9M | $2.83M |
| Supplementary Data | |||||||||||
| Total Debt | $155K | $0 | $0 | $8K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$61.68M | -$45.82M | -$7.27M | -$8.18M | -$20.3M | -$16.74M | -$13.21M | -$6.89M | -$8.98M | -$2.07M | -$2.01M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Operating Activities | |||||||||||
| Net Income | -$13.72M | -$15.59M | -$8.4M | -$10.52M | -$9.1M | -$6.3M | -$4.22M | -$3.23M | -$16.55M | -$1.19M | -$687K |
| Depreciation & Amortization | $0 | $0 | $0 | $0 | $0 | $6.51M | $0 | $3.33M | $2.1M | $1.19M | $689K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $4.84M | $1.14M | $1.9M | $1.64M | $1.47M | $1.32M | $1.01M | $529K | $305K | $0 | $0 |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $388K | $507K | -$1.33M | $1.48M | $404K | $448K | $244K | $88K | $247K | -$9K | $74K |
| Other Working Capital | -$2.99M | $2.99M | -$20K | $168K | -$86K | -$4K | -$48K | -$276K | -$127K | $298 | -$23K |
| Total Working Capital Change | -$2.61M | $3.5M | -$1.35M | $1.65M | $318K | $444K | $196K | -$188K | $121K | -$9K | $51K |
| Other Non-Cash Items | -$716K | $4.54M | $0 | $0 | $0 | -$6.63M | $0 | -$3.33M | $11.4M | -$1.19M | -$689K |
| Net Cash from Operating | -$12.2M | -$6.4M | -$7.86M | -$7.23M | -$7.32M | -$4.66M | -$3.02M | -$2.89M | -$2.63M | -$1.19M | -$636K |
| Investing Activities | |||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$87.15M | -$15.32M | -$7.88M | -$4.92M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $23.7M | $986K | $12.81M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$63.45M | -$14.34M | $4.93M | -$4.92M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Activities | |||||||||||
| Debt Repaid | - | - | - | - | - | -$122K | - | - | - | - | - |
| Common Stock Issuance | $127.71M | $59.4M | $2.07M | $109K | $10.93M | $8.18M | $10.22M | -$206K | $4.71M | $1.26M | $3.44M |
| Common Stock Repurchases | -$35M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$1.13M | -$104K | -$47K | -$76K | -$46K | -$116K | -$875K | -$206K | $4.83M | $0 | $3.44M |
| Net Cash from Financing | $91.57M | $59.29M | $2.03M | $33K | $10.88M | $8.18M | $9.35M | -$206K | $9.54M | $1.26M | $3.44M |
| Forex Effect | $97K | $494 | -$17K | -$3K | $5K | $3K | -$9K | -$2K | $0 | $0 | $0 |
| Net Change in Cash | $16.02M | $38.55M | -$920K | -$12.12M | $3.57M | $3.52M | $6.32M | -$2.89M | $6.91M | $68K | $2.81M |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$12.2M | -$6.4M | -$7.86M | -$7.23M | -$7.32M | -$4.66M | -$3.02M | -$2.89M | -$2.63M | -$1.19M | -$636K |
| Capital Expenditure | $0 | $0 | $0 | $0 | $1 | $0 | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$12.2M | -$6.4M | -$7.86M | -$7.23M | -$7.32M | -$4.66M | -$3.02M | -$2.89M | -$2.63M | -$1.19M | -$636K |
| Cash at Beginning | $45.82M | $7.27M | $8.19M | $20.3M | $16.74M | $13.21M | $6.89M | $9.78M | $2.87M | $2.81M | -$800K |
| Cash at End | $61.83M | $45.82M | $7.27M | $8.19M | $20.3M | $16.74M | $13.21M | $6.89M | $9.78M | $2.87M | $2.01M |